Literature DB >> 21817119

Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Yusuf Kasirye1, Janaki Ram Manne, Narendranath Epperla, Sowjanya Bapani, Romel Garcia-Montilla.   

Abstract

Apical hypertrophic cardiomyopathy (AHC) is a rare variant of hypertrophic cardiomyopathy. Since its description by Sakamoto in 1976 in Japanese patients, our understanding of this entity has evolved. Although cardiac magnetic resonance imaging has emerged as the gold standard for diagnosing AHC, clinical attention must be drawn to the unique electrocardiographic features that provide the initial clues to making the diagnosis. In this case, we present a 47-year-old man with AHC who presented with recurrent syncope, but anomalies on his electrocardiogram went unnoticed on two clinical encounters. He was subsequently admitted to our service and rapidly diagnosed after we observed the very classical findings in the plain twelve lead electrocardiogram done at the time of admission. In a clinical encounter involving a patient presenting with recurrent syncope, special attention must be focused on the electrocardiogram to decipher the unique diagnostic features it might show.

Entities:  

Mesh:

Year:  2011        PMID: 21817119      PMCID: PMC3280460          DOI: 10.3121/cmr.2011.986

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  32 in total

1.  Apical hypertrophic cardiomyopathy in an adolescent.

Authors:  Nicole A Abdy; Santiago O Valdes; Vincent L Sorrell; Scott E Klewer; Brent J Barber
Journal:  Congenit Heart Dis       Date:  2010 Mar-Apr       Impact factor: 2.007

2.  Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy.

Authors:  Hartzell V Schaff; Morgan L Brown; Joseph A Dearani; Martin D Abel; Steve R Ommen; Paul Sorajja; A Jamil Tajik; Rick A Nishimura
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03       Impact factor: 5.209

3.  Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging.

Authors:  G Pons-Lladó; F Carreras; X Borrás; J Palmer; J Llauger; A Bayés de Luna
Journal:  Am J Cardiol       Date:  1997-06-15       Impact factor: 2.778

4.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

5.  [Clinical characteristics and cardiac events in elderly patients with apical hypertrophic cardiomyopathy].

Authors:  Y Suganuma; K Shinmura; H Hasegawa; M Tani; Y Nakamura
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1997-06

6.  Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.

Authors:  K Okishige; T Sasano; K Yano; K Azegami; K Suzuki; K Itoh
Journal:  Intern Med       Date:  2001-05       Impact factor: 1.271

7.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  ECG pattern of left ventricular hypertrophy in nonobstructive hypertrophic cardiomyopathy: the significance of the mid-precordial changes.

Authors:  C H Chen; M Nobuyoshi; C Kawai
Journal:  Am Heart J       Date:  1979-06       Impact factor: 4.749

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.

Authors:  Lorenzo Monserrat; Manuel Hermida-Prieto; Xusto Fernandez; Isabel Rodríguez; Carlos Dumont; Laura Cazón; Margarita G Cuesta; Carlos Gonzalez-Juanatey; Jesús Peteiro; Nemesio Alvarez; Manuel Penas-Lado; Alfonso Castro-Beiras
Journal:  Eur Heart J       Date:  2007-07-04       Impact factor: 29.983

View more
  3 in total

1.  Sudden cardiac arrest in hypertrophic cardiomyopathy with dynamic cavity obstruction: The case for a decatecholaminisation strategy.

Authors:  Cosmin Balan; Adrian View-Kim Wong
Journal:  J Intensive Care Soc       Date:  2017-10-09

2.  Management of a Rare Variant of Hypertrophic Cardiomyopathy.

Authors:  Sidra Khalid; Murtaza Sundhu; Alinda Sarma; Bicky Thapa; Praful Maroo
Journal:  Cureus       Date:  2018-01-16

3.  Ventricular Fibrillation Cardiac Arrest in African American Male with Apical Hypertrophic Cardiomyopathy.

Authors:  Giselle Volney; Habiba Wada; Michael Tatusov
Journal:  Cureus       Date:  2018-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.